Dosimetry and radiation safety context

In short: Radioactivity in the body falls for two reasons at once: decay and elimination. Their combination is the effective half-life.

Two clocks

Physical half-life is fixed by the nucleus. Biological half-life describes how fast the body clears the compound, and it varies between people, organs and situations.

Combining them

For a single exponential process the effective half-life satisfies 1/T_eff = 1/T_phys + 1/T_bio, so it is always shorter than either. Real biology is rarely a single exponential, which is why measured data matter more than formulas.

Takeaways

• The formula above is a general physics relationship, not a patient calculation.

In short: Three quantities with different jobs. Mixing them up is the most common error in public discussions of radiation.

Absorbed dose (gray)

Absorbed dose is energy deposited per unit mass, measured in gray (one joule per kilogram). It is a physical quantity and the one used in therapy dosimetry research.

Equivalent and effective dose (sievert)

Equivalent dose weights absorbed dose by radiation type (alpha particles are weighted more than photons). Effective dose further weights organs by their sensitivity and sums them. It is designed for radiation protection of populations.

A key limitation

International radiation protection guidance cautions against using effective dose to estimate an individual’s risk. It is a protection quantity, not a personal risk calculator.

In short: Internal dosimetry combines how much activity sits in each organ over time with how much of the emitted energy each target absorbs.

Two ingredients

The MIRD formalism expresses the absorbed dose to a target region as the time-integrated activity in each source region multiplied by an S value: the absorbed dose to the target per decay in the source. Time-integrated activity comes from serial measurements; S values come from physics simulations in reference anatomical models.

Organ-level and voxel-level

Organ-level dosimetry uses whole-organ averages. Voxel-level methods use 3D images and dose kernels or Monte Carlo simulation to map dose within organs and lesions. Post-therapy quantitative SPECT/CT is increasingly used in research.

Why RadioGx has no calculator

Patient-specific dosimetry depends on calibrated imaging, timing, segmentation, organ masses, models and professional judgment. A web form cannot do that safely. RadioGx explains the concept and links to the professional resources.

In short: Why kidneys, salivary glands and bone marrow come up in radioligand therapy research, and how to read activity statements in labels.

Organs at risk

Organs that take up or clear a radiopharmaceutical can receive radiation they do not need. For peptide and PSMA radioligands, research often focuses on kidneys, salivary glands and bone marrow. Which organs matter depends on the compound.

Activity in labels and trials

Labels and trial protocols state administered activities and schedules. Some research explores adjusting activity using dosimetry instead of fixed activities. These are professional and regulatory questions, and statements in labels or papers are not instructions for anyone.

In short: ALARA, time, distance and shielding, and the regulators and frameworks that set the rules.

Everyday principles

As low as reasonably achievable (ALARA) guides practice. Workers reduce exposure by limiting time near sources, increasing distance and using shielding. Facilities monitor staff and areas.

Rules come from regulators

In the United States, the Nuclear Regulatory Commission and Agreement States license medical use of radioactive materials and set conditions such as patient release criteria. In the European Union, the Basic Safety Standards Directive (2013/59/Euratom) frames national rules. In India, the Atomic Energy Regulatory Board regulates radiation facilities. The IAEA publishes international safety standards.

Where RadioGx stops

RadioGx links to these sources. It does not interpret regulations for a facility or person and does not certify anything.